FoRx Therapeutics Raises USD 50M in Series A Funding to Advance Phase 1 Clinical Development of PARG Inhibitor FORX-428.
Amount Raised
$50 Million
Round Type
Series A
BaselBiotechnologyHealth CareTherapeuticsInvestors
Description
FoRx Therapeutics has successfully closed a USD 50 million Series A financing round, led by existing investors including EQT Life Sciences and Pfizer Ventures. The funds will advance the Phase 1 clinical development of its lead drug candidate, FORX-428, targeting advanced solid tumors. Initial clinical data is expected to be ready by mid-2026. This financing builds on previous investments aimed at supporting the drug's progression through clinical trials.
Quick answer
FoRx Therapeutics raised $50 Million in a Series A round, dated December 18, 2025. Investors: Novartis Venture Fund, M Ventures, EQT Life Sciences and Pfizer Ventures. FoRx Therapeutics is based in Basel, Basel City, Switzerland.
- How much did FoRx Therapeutics raise?
- FoRx Therapeutics raised $50 Million in a Series A round on December 18, 2025.
- Who invested in FoRx Therapeutics?
- Novartis Venture Fund, M Ventures, EQT Life Sciences and Pfizer Ventures are named as investors in this round.
- What does FoRx Therapeutics do?
- FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland.
- Where is FoRx Therapeutics based and how big is it?
- FoRx Therapeutics is based in Basel, Basel City, Switzerland. Fundz records about 36 employees.
- Who are the decision-makers at FoRx Therapeutics?
- Fundz holds 2 contacts at FoRx Therapeutics, including the Vice President, Head of Chemistry. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as FoRx Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- CytoDyn raised $19M on January 30, 2026.
- PranaX raised $17M (Series A) on January 29, 2026.
- Tenpoint Therapeutics raised $235M (Series B) on January 29, 2026.
- Stellular Bio raised an undisclosed amount (Funding Round) on January 28, 2026.
- Altido Bio raised $13M (Seed) on January 28, 2026.
- CraniUS raised $20M (Series B) on January 28, 2026.
Who to call at FoRx Therapeutics, and when
A new round usually means FoRx Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day FoRx Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at FoRx Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at FoRx Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment FoRx Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansFoRx Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.